• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 炎症导致尿液细胞因子升高,并导致 COVID-19 相关性膀胱炎(CAC)。

COVID-19 inflammation results in urine cytokine elevation and causes COVID-19 associated cystitis (CAC).

机构信息

Department of Urology, Beaumont Health System, Royal Oak, MI, USA; Oakland University William Beaumont School of Medicine, Rochester Hills, MI, USA.

Detroit Medical Center, Detroit, MI, USA; John D. Dingell VA Medical Center, Detroit, MI, USA.

出版信息

Med Hypotheses. 2020 Dec;145:110375. doi: 10.1016/j.mehy.2020.110375. Epub 2020 Nov 5.

DOI:10.1016/j.mehy.2020.110375
PMID:33213997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7644255/
Abstract

Coronavirus disease 2019 (COVID-19) causes a wide range of symptoms, including several unexpected symptoms such as loss of taste, skin changes, and eye problems. We recently observed patients with documented COVID-19 develop de novo severe genitourinary symptoms, most notably urinary frequency of ≥ 13 episodes/24 h and nocturia ≥ 4 episodes/night. We call these associated urinary symptoms COVID-19 associate cystitis (CAC). COVID-19 severity is associated with inflammation. We collected urine samples from COVID-19 patients, including patients with CAC, and found elevation of proinflammatory cytokines also in the urine. It has been previously shown that patients with urinary incontinence and ulcerative interstitial cystitis/bladder pain syndrome have elevated urinary inflammatory cytokines compared to normal controls. We therefore hypothesize that CAC, with presentation of de novo severe urinary symptoms, can occur in COVID-19 and is caused by increased inflammatory cytokines that are released into the urine and/or expressed in the bladder. The most important implications of our hypothesis are: 1) Physician caring for COVID-19 patients should be aware of COVID-19 associate cystitis (CAC); 2) De novo urinary symptoms should be included in the symptom complex associated with COVID-19; and 3) COVID-19 inflammation may result in bladder dysfunction.

摘要

新型冠状病毒病 2019(COVID-19)可引起多种症状,包括一些意想不到的症状,如味觉丧失、皮肤变化和眼部问题。我们最近观察到有记录的 COVID-19 患者出现新发严重的泌尿生殖系统症状,最明显的是≥13 次/24 小时的尿频和≥4 次/夜的夜尿症。我们将这些相关的泌尿症状称为 COVID-19 相关膀胱炎(CAC)。COVID-19 的严重程度与炎症有关。我们从 COVID-19 患者(包括 CAC 患者)中收集了尿液样本,发现尿液中促炎细胞因子也升高。以前已经表明,与正常对照组相比,患有尿失禁和溃疡性间质性膀胱炎/膀胱疼痛综合征的患者尿液中促炎细胞因子升高。因此,我们假设 CAC 以新发严重的泌尿症状为特征,可能发生在 COVID-19 中,并由释放到尿液中和/或在膀胱中表达的增加的炎症细胞因子引起。我们假设的最重要意义在于:1)照顾 COVID-19 患者的医生应该意识到 COVID-19 相关膀胱炎(CAC);2)新发的泌尿症状应包括在与 COVID-19 相关的症状综合中;3)COVID-19 炎症可能导致膀胱功能障碍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71b0/7644255/e93c30b36ece/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71b0/7644255/e93c30b36ece/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71b0/7644255/e93c30b36ece/gr1_lrg.jpg

相似文献

1
COVID-19 inflammation results in urine cytokine elevation and causes COVID-19 associated cystitis (CAC).COVID-19 炎症导致尿液细胞因子升高,并导致 COVID-19 相关性膀胱炎(CAC)。
Med Hypotheses. 2020 Dec;145:110375. doi: 10.1016/j.mehy.2020.110375. Epub 2020 Nov 5.
2
[Lower urinary tract symptoms and COVID-19].[下尿路症状与新型冠状病毒肺炎]
Urologiia. 2021 Nov(5):78-83.
3
COVID-associated cystitis: the culprit behind the bladder woes post-COVID infection? A review.COVID 相关性膀胱炎:COVID 感染后膀胱不适的罪魁祸首?综述。
Int Urol Nephrol. 2023 Oct;55(10):2367-2372. doi: 10.1007/s11255-023-03700-3. Epub 2023 Jul 6.
4
Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis.膀胱疼痛综合征/间质性膀胱炎中的膀胱传入神经兴奋性过高
Int J Urol. 2014 Apr;21 Suppl 1(0 1):18-25. doi: 10.1111/iju.12308.
5
Long COVID and COVID-19-associated cystitis (CAC).长新冠和 COVID-19 相关膀胱炎(CAC)。
Int Urol Nephrol. 2022 Jan;54(1):17-21. doi: 10.1007/s11255-021-03030-2. Epub 2021 Nov 17.
6
Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder Syndrome.感觉神经支配过度区分膀胱疼痛综合征/间质性膀胱炎与膀胱过度活动症。
J Urol. 2017 Jan;197(1):159-166. doi: 10.1016/j.juro.2016.06.089. Epub 2016 Jul 1.
7
Hypersensitive bladder: a solution to confused terminology and ignorance concerning interstitial cystitis.膀胱过敏:解决间质性膀胱炎术语混淆和认知不足问题的一种方法。
Int J Urol. 2014 Apr;21 Suppl 1:43-7. doi: 10.1111/iju.12314.
8
Nocturia in interstitial cystitis/painful bladder syndrome.间质性膀胱炎/膀胱疼痛综合征中的夜尿症。
Urology. 2011 Jun;77(6):1308-12. doi: 10.1016/j.urology.2011.02.012.
9
Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy.临床表型不能区分 Hunner 病变型间质性膀胱炎/膀胱疼痛综合征:重新审视膀胱镜的作用。
J Urol. 2016 Oct;196(4):1136-40. doi: 10.1016/j.juro.2016.04.067. Epub 2016 Apr 23.
10
Urinary Microbiome and Cytokine Levels in Women With Interstitial Cystitis.间质性膀胱炎女性的尿液微生物群和细胞因子水平
Obstet Gynecol. 2017 Mar;129(3):500-506. doi: 10.1097/AOG.0000000000001892.

引用本文的文献

1
Urinary Bladder Perforation: A Forensic Case Report and Brief Literature Review.膀胱穿孔:一份法医病例报告及文献综述
Cureus. 2025 Jun 26;17(6):e86831. doi: 10.7759/cureus.86831. eCollection 2025 Jun.
2
Post-COVID-19 neurogenic lower urinary tract dysfunction in pediatrics: A case series of clinical manifestations resembling Elsberg syndrome.儿童新型冠状病毒肺炎后神经源性下尿路功能障碍:一组临床表现类似埃尔茨伯格综合征的病例系列
Bladder (San Franc). 2025 Jan 10;11(4):e21200024. doi: 10.14440/bladder.2024.0043. eCollection 2024.
3
Diagnosis, Severity, and Prognosis from Potential Biomarkers of COVID-19 in Urine: A Review of Clinical and Omics Results.
尿液中新冠病毒潜在生物标志物的诊断、严重程度及预后:临床与组学结果综述
Metabolites. 2024 Dec 22;14(12):724. doi: 10.3390/metabo14120724.
4
Therapeutic efficacy and short-term durability of trans-urethral amniotic bladder injections for the treatment of refractory COVID-associated cystitis.经尿道羊膜膀胱注射治疗难治性新型冠状病毒肺炎相关膀胱炎的疗效及短期持久性
Bladder (San Franc). 2024 Oct 3;11(2):e21200010. doi: 10.14440/bladder.2024.0017. eCollection 2024.
5
Prolonged urinary retention in COVID-19 survivors: observational study.COVID-19 幸存者的长期尿潴留:观察性研究。
Rev Assoc Med Bras (1992). 2024 Nov 11;70(11):e20240845. doi: 10.1590/1806-9282.20240845. eCollection 2024.
6
Is detrusor underactivity the urodynamic characteristic of long-COVID in patients with benign prostate hyperplasia?逼尿肌活动低下是良性前列腺增生患者长新冠的尿动力学特征吗?
Medicine (Baltimore). 2024 Oct 11;103(41):e40156. doi: 10.1097/MD.0000000000040156.
7
Long-term effect of non-severe COVID-19 on pulmonary function, exercise capacities and physical activities: a cross-section study in Sakaka Aljouf.沙特阿吉兰省 Sakaka 地区非重症 COVID-19 对肺功能、运动能力和体力活动的长期影响:一项横断面研究。
F1000Res. 2024 Mar 4;12:809. doi: 10.12688/f1000research.133516.3. eCollection 2023.
8
Lower Urinary Tract Symptoms in a prospective cohort of COVID-19 survivors.前瞻性队列研究中 COVID-19 幸存者的下尿路症状。
Int Braz J Urol. 2024 May-Jun;50(3):287-295. doi: 10.1590/S1677-5538.IBJU.2023.0546.
9
The Role of Extracellular Vesicles in SARS-CoV-2-Induced Acute Kidney Injury: An Overview.细胞外囊泡在新冠病毒诱导的急性肾损伤中的作用:综述
Life (Basel). 2024 Jan 23;14(2):163. doi: 10.3390/life14020163.
10
Identification of shared pathogenetic mechanisms between COVID-19 and IC through bioinformatics and system biology.通过生物信息学和系统生物学鉴定 COVID-19 和 IC 之间的共同发病机制。
Sci Rep. 2024 Jan 24;14(1):2114. doi: 10.1038/s41598-024-52625-z.